Pavel Darling, Vice President, Analysis Group, Inc. to Speak at TKG Navigating Antitrust Issues in the Pharmaceutical and Life Science Industries
The Knowledge Group, the leading producer of regulatory focused webcasts, has announced today that Pavel Darling, Vice President, Analysis Group will speak at its webcast entitled, “Navigating Antitrust Issues in the Pharmaceutical and Life Science Industries: Key Trends and Challenges Explored.” This event is scheduled for Tuesday, June 21, 2022, from 3:00 PM to 4:30 PM ET
- (1888PressRelease) June 11, 2022 - For further details, please visit:
https://knowledgewebcasts.com/know-portfolio/navigating-antitrust-issues-in-the-pharmaceutical-and-life-science-industries-cle/
About Pavel Darling
Pavel Darling, a Vice President in Analysis Group’s Boston office, provides consulting and expert testimony support in complex litigation matters. He has performed quantitative analyses to address litigation, strategy, and policy questions, primarily in the health care industry, and has extensive experience with a range of sophisticated economic modeling tools and techniques. Mr. Darling’s healthcare work frequently deals with antitrust issues including pharmaceutical reverse payment settlements, intellectual property and patent infringement, and competition, and covers all stages of litigation including class certification, liability, and damages assessments. Mr. Darling received his M.B.A. at the MIT Sloan School of Management.
About Analysis Group, Inc.
Analysis Group is one of the largest international economics consulting firms, with more than 1,000 professionals across 14 offices in North America, Europe, and Asia. Since 1981, we have provided expertise in economics, finance, health care analytics, and strategy to top law firms, Fortune Global 500 companies, and government agencies worldwide. Our internal experts, together with our network of affiliated experts from academia, industry, and government, offer our clients exceptional breadth and depth of expertise.
Event Summary
Antitrust litigation in the life sciences sector has continued to grow and evolve, with a rapid mix of innovate theories and impactful court decisions over the past few years. Pharmaceutical companies must constantly consider the changing landscape as they pursue their business strategies to avoid legal pitfalls, and attorneys must stay up-to-date on decisions and strategies that are shaping the next generation of litigation.
Listen as a panel of distinguished thought leaders organized by The Knowledge Group provide the audience with an in-depth discussion of the trends, developments, and critical issues surrounding pharmaceutical antitrust matters. Our panel will provide the audience with insight on recent cases that are shaping the litigation battlefields of tomorrow, as well as thoughtful analysis of the key issues that separate the cases. Using a phased approach, they will walk you through the background of these key cases, and separate out the implications for class certification, merits issue, and how expert testimony can be used most effectively.
Key topics that will be discussed in this course are:
• Recent Pharmaceutical Antitrust Cases: An Overview
• Critical Issues and Challenges in Class Certification
• Considerations for Complex Merits Issues
• Practical Guidance for Lifecycle Management
• Implications for Expert Testimony
• What Lies Ahead
About The Knowledge Group
Founded in November 2006, The Knowledge Group has been at the forefront of providing quality continuing education programs for lawyers, accountants, financial executives, risk and compliance specialists, human resources professionals, technology officers, and business consultants in a wide range of industries.
The Knowledge Group strives to be the best-in-class provider of continuing education by bringing forth relevant content you can’t get anywhere else.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam